Journal of Nuclear Medicine, 0161-5505

Journal

More filtering options
  1. 2020
  2. Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients

    Aseem Anand, Elin Trägårdh, Lars Edenbrandt, Lars Beckman, Jan Henry Svensson, Camilla Thellenberg, Anders Widmark, Jon Kindblom, Anders Ullén & Anders Bjartell, 2020 May 1, In : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 61, 5, p. 671-675 5 p.

    Research output: Contribution to journalArticle

  3. 2019
  4. Recombinant alpha-1-microglobulin is a potential kidney protector in 177Lu-octreotate treatment of neuroendocrine tumors

    Charlotte Andersson, Emman Shubbar, Emil Schuler, Bo Åkerström, Magnus Gram & Eva Forssell-Aronsson, 2019 Mar 29, In : Journal of Nuclear Medicine. 60, 11, p. 1600-1604

    Research output: Contribution to journalArticle

  5. A prospective observational study to evaluate the effects of long-acting somatostatin analogs on 68Ga-DOTATATE uptake in patients with neuroendocrine tumors

    Anni Gålne, Helén Almquist, Martin Almquist, Cecilia Hindorf, Tomas Ohlsson, Erik Nordenström, Anna Sundlöv & Elin Trägårdh, 2019, In : Journal of Nuclear Medicine. 60, 12, p. 1717-1723

    Research output: Contribution to journalArticle

  6. Bone marrow absorbed doses and correlations with hematological response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases

    Linn Hagmarker, Johanna Svensson, Tobias Ryden, Martijn van Essen, Anna Sundlöv, Katarina Sjögreen Gleisner, Peter Gjertsson & Peter Bernhardt, 2019, In : Journal of Nuclear Medicine. 60, 10, p. 1406-1413

    Research output: Contribution to journalArticle

  7. 2017
  8. Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details

    Glenn D Flux, Frederik A Verburg, Carlo Chiesa, Manuel Bardiès, Katarina Sjögreen Gleisner, Barbara Hertz, Mark Konijnenberg, Michael Lassmann, Michael Ljungberg, Markus Luster, Michael Stabin & Lidia Strigari, 2017 May, In : Journal of Nuclear Medicine. 58, 5, p. 862

    Research output: Contribution to journalArticle

  9. Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology

    Andreas Hahn, Martin Schain, Maria Erlandsson, Petter Sjölin, Gregory James, Olof Strandberg, Douglas Hägerström, Rupert Lanzenberger, Jonas Jögi, Tomas G Olsson, Ruben Smith & Oskar Hansson, 2017, In : Journal of Nuclear Medicine. 58, 4, p. 623-631

    Research output: Contribution to journalArticle

  10. 2016
  11. A preanalytic validation study of automated bone scan index: Effect on accuracy and reproducibility due to the procedural variabilities in bone scan image acquisition

    Aseem Anand, Michael J. Morris, Reza Kaboteh, Mariana Reza Felix, Elin Trägårdh, Naofumi Matsunaga, Lars Edenbrandt, Anders Bjartell, Steven M. Larson & David Minarik, 2016 Dec 1, In : Journal of Nuclear Medicine. 57, 12, p. 1865-1871 7 p.

    Research output: Contribution to journalArticle

  12. Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.

    Aseem Anand, Michael J Morris, Reza Kaboteh, Lena Båth, May Sadik, Peter Gjertsson, Milan Lomsky, Lars Edenbrandt, David Minarik & Anders Bjartell, 2016, In : Journal of Nuclear Medicine. 57, 1, p. 41-45

    Research output: Contribution to journalArticle

  13. MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.

    Michael Ljungberg, Anna Celler, Mark W Konijnenberg, Keith F Eckerman, Yuni K Dewaraja & Katarina Sjögreen Gleisner, 2016, In : Journal of Nuclear Medicine. 57, 1, p. 151-162

    Research output: Contribution to journalArticle

  14. 2015
  15. A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of Ra-223-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases

    Sarah J. Chittenden, Cecilia Hindorf, Christopher C. Parker, Valerie J. Lewington, Brenda E. Pratt, Bernadette Johnson & Glenn D. Flux, 2015, In : Journal of Nuclear Medicine. 56, 9, p. 1304-1309

    Research output: Contribution to journalArticle

  16. The water-perfusable tissue fraction of colorectal cancer metastases is increased by the selective PDGF-receptor inhibitor imatinib but not the IL-1 receptor antagonist anakinra, a study using serial dynamic 15O-water PET.

    Mark Lubberink, Sandeep S V Golla, My Jonasson, Kristofer Rubin, Bengt Glimelius, Jens Sörensen & Peter Nygren, 2015, In : Journal of Nuclear Medicine. 56, 8, p. 1144-1149

    Research output: Contribution to journalArticle

  17. 2014
  18. 188Re-ZHER2:V2, a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment.

    Mohamed Altai, Helena Wållberg, Hadis Honarvar, Joanna Strand, Anna Orlova, Zohreh Varasteh, Mattias Sandström, John Löfblom, Erik Larsson, Sven-Erik Strand, Mark Lubberink, Stefan Ståhl & Vladimir Tolmachev, 2014, In : Journal of Nuclear Medicine. 55, 11, p. 1842-1848

    Research output: Contribution to journalArticle

  19. A Compartmental Model of Mouse Thrombopoiesis and Erythropoiesis to Predict Bone Marrow Toxicity After Internal Irradiation.

    Nicolas Sas, Julie Rousseau, Frédérique Nguyen, Elise Bellec, Erik Larsson, Sonia Becavin, Cecilia Hindorf, Jérôme Abadie, Nicolas Chouin & Jacques Barbet, 2014, In : Journal of Nuclear Medicine. 55, 8, p. 1355-1360

    Research output: Contribution to journalArticle

  20. 2013
  21. Brain glucose transport and phosphorylation under acute insulin-induced hypoglycemia in mice: an 18F-FDG PET study

    Malte F Alf, João M N Duarte, Roger Schibli, Rolf Gruetter & Stefanie D Krämer, 2013 Dec, In : Journal of Nuclear Medicine. 54, 12, p. 2153-60 8 p.

    Research output: Contribution to journalArticle

  22. MIRD Pamphlet No. 24: Guidelines for Quantitative I-131 SPECT in Dosimetry Applications

    Yuni K. Dewaraja, Michael Ljungberg, Alan J. Green, Pat B. Zanzonico & Eric C. Frey, 2013, In : Journal of Nuclear Medicine. 54, 12, p. 2182-2188

    Research output: Contribution to journalArticle

  23. 2012
  24. A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients

    Augusto Giussani, Tilman Janzen, Helena Uusijärvi, Federico Tavola, Maria Zankl, Marie Sydoff, Anders Bjartell, Sigrid Leide Svegborn, Marcus Söderberg, Sören Mattsson, Christoph Hoeschen & Marie-Claire Cantone, 2012, In : Journal of Nuclear Medicine. 53, 6, p. 985-993

    Research output: Contribution to journalArticle

  25. MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy

    Y. K. Dewaraja, E. C. Frey, G. Sgouros, A. B. Brill, P. Roberson, P. B. Zanzonico & Michael Ljungberg, 2012, In : Journal of Nuclear Medicine. 53, 8, p. 1310-1325

    Research output: Contribution to journalArticle

  26. Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition.

    Vladimir Tolmachev, Thuy Tran, Rosik Daniel, Sjöberg Anna, Abrahamsén Lars & Orlova Anna, 2012, In : Journal of Nuclear Medicine. 53, 6, p. 953-960

    Research output: Contribution to journalArticle

  27. 2010
  28. 2009
  29. An Improved Method for Automatic Segmentation of the Left Ventricle in Myocardial Perfusion SPECT.

    Helen Fransson, Joey Ubachs, Martin Ugander, Håkan Arheden & Einar Heiberg, 2009, In : Journal of Nuclear Medicine. 50, 2, p. 205-213

    Research output: Contribution to journalArticle

  30. Improved Classifications of Planar Whole-Body Bone Scans Using a Computer-Assisted Diagnosis System: A Multicenter, Multiple-Reader, Multiple-Case Study

    May Sadik, Madis Suurkula, Peter Höglund, Andreas Jarund & Lars Edenbrandtl, 2009, In : Journal of Nuclear Medicine. 50, 3, p. 368-375

    Research output: Contribution to journalArticle

  31. 2008
  32. High 18F-FDG Uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients

    Johan Wassélius, Jonas Malmstedt, Bo Kalin, Stig Larsson, Anders Sundin, Ulf Hedin & Hans Jacobsson, 2008 Oct, In : Journal of Nuclear Medicine. 49, 10, p. 1601-5 5 p.

    Research output: Contribution to journalArticle

  33. Computer-Assisted Interpretation of Planar Whole-Body Bone Scans.

    May Sadik, Iman Hamadeh, Pierre Nordblom, Madis Suurkula, Peter Höglund, Mattias Ohlsson & Lars Edenbrandt, 2008, In : Journal of Nuclear Medicine. 49, 12, p. 1958-1965

    Research output: Contribution to journalArticle

  34. Merits of V/Q SPECT scintigraphy compared with CTPA in imaging of pulmonary embolism

    Paul J Roach, Paul Thomas, Marika Bajc & Björn Jonson, 2008, In : Journal of Nuclear Medicine. 49, 1, p. 167-168

    Research output: Contribution to journalLetter

  35. 2007
  36. Parametric images of antibody pharmacokinetics based on serial quantitative whole-body imaging and blood sampling

    Katarina Sjögreen Gleisner, Mattias Nickel, Ola Lindén, Kjell Erlandsson, Karin Wingårdh & Sven-Erik Strand, 2007, In : Journal of Nuclear Medicine. 48, 8, p. 1369-1378

    Research output: Contribution to journalArticle

  37. Reduced myelotoxicity with sustained tumor concentration of radioimmunoconjugates in rats after extracorporeal depletion.

    Linda Mårtensson, Rune Nilsson, Tomas G Ohlsson, Hans Olov Sjögren, Sven-Erik Strand & Jan Tennvall, 2007, In : Journal of Nuclear Medicine. 48, 2, p. 269-276

    Research output: Contribution to journalArticle

  38. 2005
  39. Accurate dosimetry in I-131 radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation

    Y K Dewaraja, S J Wilderman, Michael Ljungberg, K F Koral, K Zasadny & M S Kaminiski, 2005, In : Journal of Nuclear Medicine. 46, 5, p. 840-849

    Research output: Contribution to journalArticle

  40. 2004
  41. 68Ga-labeled oligonucleotides for in vivo imaging with PET

    Anne Roivainen, Tuula Tolvanen, Satu Salomäki, Gabor Lendvai, Irina Velikyan, Petri Numminen, Maria Välilä, Hannu Sipilä, Mats Bergström, Pirkko Härkönen, Harri Lönnberg & Bengt Långström, 2004, In : Journal of Nuclear Medicine. 45, 2, p. 347-355

    Research output: Contribution to journalArticle

  42. Evaluation of parameters influencing s values in mouse dosimetry.

    Cecilia Hindorf, Michael Ljungberg & Sven-Erik Strand, 2004, In : Journal of Nuclear Medicine. 45, 11, p. 1960-1965

    Research output: Contribution to journalArticle

  43. 2002
  44. Lung ventilation/perfusion SPECT in the artificially embolized pig.

    Marika Bajc, Ulrika Bitzén, Berit Olsson, Valéria Perez de Sá, John Palmer & Björn Jonson, 2002, In : Journal of Nuclear Medicine. 43, 5, p. 640-647

    Research output: Contribution to journalArticle

  45. 2001
  46. Comprehensive ventilation/perfusion SPECT

    John Palmer, Ulrika Bitzén, Björn Jonson & Marika Bajc, 2001, In : Journal of Nuclear Medicine. 42, 8, p. 1288-1294

    Research output: Contribution to journalArticle

  47. Quantitative Gated SPECT: A Monte Carlo evaluation

    Michael Ljungberg, F Eriksson, J Dahlström & Sven-Erik Strand, 2001, In : Journal of Nuclear Medicine. 42, 5, p. 194P-194P

    Research output: Contribution to journalLetter

  48. Registration of emission and transmission whole-body scintillation-camera images

    Katarina Sjögreen Gleisner, Michael Ljungberg, Karin Wingårdh, Kjell Erlandsson & Sven-Erik Strand, 2001, In : Journal of Nuclear Medicine. 42, 10, p. 1563-1570

    Research output: Contribution to journalArticle

Previous 1 2 Next